Wednesday - June 17, 2026
Hospitalizations, Enforcement Gaps, Influencers Tied to Unapproved Retatrutide Products
June 16, 2026
WASHINGTON, June 16 [Category: Political] -- Public Citizen issued the following news release:

* * *

Hospitalizations, Enforcement Gaps, Influencers Tied to Unapproved Retatrutide Products

*

WASHINGTON, D.C. -The U.S. Food and Drug Administration (FDA) has allowed a dangerous market for retatrutide -an unapproved weight loss drug -to expand unchecked, even as at least 14 people have been reported hospitalized related to its use, according to a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products